Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapy
about
Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapy
description
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
article scientifique (publié 2009/04/15)
@fr
articolo scientifico (pubblicato il 2009/04/15)
@it
artigo científico (publicado na 2009/04/15)
@pt
artikull shkencor
@sq
artículu científicu espublizáu en 2009
@ast
scientific article (publication date: 15 April 2009)
@en
vedecký článok (publikovaný 2009/04/15)
@sk
vetenskaplig artikel (publicerad på 2009/04/15)
@sv
name
Lamivudine for preventing reac ...... ergo immunosuppressive therapy
@ast
Lamivudine for preventing reac ...... ergo immunosuppressive therapy
@en
Lamivudine for preventing reac ...... ergo immunosuppressive therapy
@en-gb
Lamivudine for preventing reac ...... ergo immunosuppressive therapy
@nl
type
label
Lamivudine for preventing reac ...... ergo immunosuppressive therapy
@ast
Lamivudine for preventing reac ...... ergo immunosuppressive therapy
@en
Lamivudine for preventing reac ...... ergo immunosuppressive therapy
@en-gb
Lamivudine for preventing reac ...... ergo immunosuppressive therapy
@nl
prefLabel
Lamivudine for preventing reac ...... ergo immunosuppressive therapy
@ast
Lamivudine for preventing reac ...... ergo immunosuppressive therapy
@en
Lamivudine for preventing reac ...... ergo immunosuppressive therapy
@en-gb
Lamivudine for preventing reac ...... ergo immunosuppressive therapy
@nl
P2093
P2860
P1476
Lamivudine for preventing reac ...... ergo immunosuppressive therapy
@en
P2093
Abigail Fraser
Lior H Katz
Rani Tur-Kaspa
P2860
P356
10.1002/14651858.CD005264.PUB2
P577
2009-04-15T00:00:00Z